Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Operational Update

5 Jun 2026 09:00

RNS Number : 1927H
Clean Power Hydrogen PLC
05 June 2026
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO SECTION 3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

Operational Update

 

Clean Power Hydrogen Plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing company, provides a further update following the announcement on 29 May 2026 regarding the incident at the Company's test site during the third and final stage of the factory acceptance testing ("FAT3") of its MFE220 1MW unit.

 

As previously announced, an incident occurred during a standard shutdown procedure which caused damage to the electrolyser and, in line with CPH2's health, safety and environmental protection processes, all operations were suspended at that point.

 

A subsequent inspection at the test site and review of all available data indicate that the damage to the unit is significant and that it will not be possible to repair the system to allow the testing process to continue. The Company's insurers were immediately informed at the time of the incident and have visited the test site to begin their assessment. The exact cause of the incident remains under investigation and that process is expected to continue.

 

Based on the preliminary review completed to date, the Company's Chief Technical Officer and Chief Operations Director have advised the Board that, in their opinion, the MFE220 unit will require substantial redesign to ensure that the mixed gas system can be operated safely in all conditions. Whilst the Board retains confidence in the potential of the technology, it has concluded that the Company does not currently have the financial, engineering or technical resources required to undertake such a programme at this time. Accordingly, the Board has decided not to recommence activities relating to FAT3 for the MFE220 electrolyser and instead will pursue alternative, non-manufacturing, commercial strategies. 

 

The Board believes that the Company's existing intellectual property, including six patent families across twelve countries, licensees, copyrights, designs, schematics, commercial relationships and more than a decade of accumulated technical knowhow have significant commercial value. As such, the Company is now actively evaluating options to maximise the value from its intellectual property and related assets, including potential commercial, licensing and strategic alternatives, which will be in the best interests of shareholders and other stakeholders.

 

The Company's working capital remains constrained and there remains material uncertainty over continuing operations whilst discussions with capital providers remain ongoing. Accordingly, trading in the Company's shares on AIM remain suspended pending further updates.

 

For more information, please contact:

 

Clean Power Hydrogen plc

+44 1302 328075

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Joint Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Hanna Leijonmarck

+44 (0)20 3772 6029

Turner Pope Investments (TPI) Limited - Joint Broker

Andy Thacker

+44 (0)20 3657 0050

Guy McDougall

 

For more information: https://www.cph2.com

 

Forward-Looking Statements

 

This announcement contains forward-looking statements. These statements relate to the Group's future prospects, developments and business strategies. Forward-looking statements are identified by their use of terms and phrases such as "potential", "estimate", "expect", "may", "will" or the negative of such terms and phrases, variations or comparable expressions, including references to assumptions. The forward-looking statements in this Announcement are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These forward-looking statements speak only as at the date of this Announcement. No statement in this Announcement is intended to constitute a profit forecast or profit estimate for any period. No representation or warranty is given as to the completeness or accuracy of the forward-looking statements contained in this Announcement. Neither the Directors nor the Company undertake any obligation to update forward-looking statements other than as required by the AIM Rules for Companies or by the rules of any other securities regulatory authority, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUMWQUPQUMA
Date   Source Headline
14th Jan 20257:00 amRNSHolding(s) in Company
8th Jan 202512:02 pmRNSResult of General Meeting and Total Voting Rights
20th Dec 20245:11 pmRNSResults of Retail Offer
19th Dec 20247:00 amRNSResult of Placing and Subscription
18th Dec 20245:09 pmRNSRetail Offer for up to £0.3 million
18th Dec 20244:42 pmRNSProposed Placing, Subscription, and Retail Offer
26th Nov 20247:00 amRNSOperational Update and Proposed Fundraising
7th Nov 20243:22 pmRNSNotification of Major Shareholdings
4th Nov 20247:00 amRNSSettlement with GHFG
4th Nov 20247:00 amRNSNew Licence Agreement and Sales Contract
15th Oct 20247:00 amRNSRenewed Contract Terms for MFE220 Sales Contracts
27th Sep 20247:00 amRNS2024 Interim Results
26th Sep 20247:00 amRNSFactory Acceptance Test for MFE110 electrolyser
5th Sep 20247:38 amRNSPublication of Interim Results
15th Aug 20247:00 amRNSLevel 2 Factory Acceptance Test Completed
29th Jul 20247:00 amRNSTR-1: Notification of major holdings
26th Jul 20247:00 amRNSTR-1:Notification of major holdings
3rd Jul 20247:00 amRNSExercise of Options - Issue of Equity
28th Jun 20248:10 amRNSLevel 1 of Factory Acceptance Test Completed
19th Jun 20245:34 pmRNSResult of AGM
18th Jun 20247:00 amRNSCE Marking Awarded
12th Jun 20247:00 amRNSHoldings in Company
23rd May 20247:00 amRNS2024 Save as You Earn Scheme
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation
27th Mar 20237:00 amRNSFabrum Solutions Ltd receives order from Obayashi
16th Mar 20237:00 amRNSPDMR Dealing
27th Feb 20237:00 amRNSLock-in Agreement Extension
8th Feb 20237:00 amRNSSave As You Earn Scheme
31st Jan 20237:00 amRNSManufacturing Agreement with Fabrum Solutions Ltd
26th Jan 20237:00 amRNSAppointment of Chief Technical Officer
22nd Dec 20227:00 amRNSAgreements Signed with Fabrum Solutions Ltd
20th Dec 20221:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.